LRP8 Regulates Lipid Metabolism to Stimulate Malignant Progression and Cisplatin Resistance in Bladder Cancer
The Kaohsiung Journal of Medical Sciences · 2025-09 · 41 (9)
DOI: 10.1002/kjm2.70042 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, online erschienen am 15.05.2025. Verfasst von Gang-Feng Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shaoxing People's Hospital, Shaoxing, China. Hauptthemen laut MEDLINE: Cisplatin, Urinary Bladder Neoplasms, Drug Resistance, Neoplasm, Lipid Metabolism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2024 Health Science and Technology Project of Zhejiang Province.
Abstract (Originalsprache)
Low‐density lipoprotein receptor‐related protein 8 (LRP8) is a crucial regulator of lipid metabolism and is implicated in the development and treatment of various cancers. However, its role in bladder cancer (BCa) remains unknown. We analyzed LRP8 expression in BCa using the TCGA database and clinical samples. We manipulated LRP8 expression in tumor cell lines using siRNA or overexpression plasmid transfection. Cell proliferation, migration, invasion, apoptosis, and drug resistance were assessed through CCK‐8, transwell, flow cytometry, and IC 50 assays. Additionally, a rescue experiment confirmed the association between LRP8 and lipid metabolism. LRP8 was significantly upregulated in BCa tissues and cells. Knockdown of LRP8 reduced tumor cell proliferation, migration, invasion, and increased apoptosis while enhancing cisplatin sensitivity. Overexpression of LRP8 boosted malignant progression and cisplatin resistance in tumor cells. The expression level of LRP8 is positively linked with the expression of lipid metabolism‐related genes, phospholipid accumulation, and triglyceride accumulation. Notably, inhibiting lipid metabolism reversed the malignant progression and cisplatin resistance induced by LRP8 overexpression. LRP8 could promote BCa malignant progression and cisplatin resistance through lipid metabolism regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Shaoxing People's Hospital, Shaoxing, China.
ORCID-Profile: Xiang-Rong Ying
Förderung
- 2024 Health Science and Technology Project of Zhejiang Province
Zitieren
APA
Wu, G. F., Luo, Z. G., Gao, K., Ren, Y., Shen, C., & Ying, X. R. (2025). LRP8 Regulates Lipid Metabolism to Stimulate Malignant Progression and Cisplatin Resistance in Bladder Cancer. The Kaohsiung Journal of Medical Sciences, 41(9). https://doi.org/10.1002/kjm2.70042
Vancouver
Wu GF, Luo ZG, Gao K, Ren Y, Shen C, Ying XR. LRP8 Regulates Lipid Metabolism to Stimulate Malignant Progression and Cisplatin Resistance in Bladder Cancer. The Kaohsiung Journal of Medical Sciences. 2025;41(9). doi:10.1002/kjm2.70042
BibTeX
@article{Wu2025,
author = {Wu, Gang-Feng and Luo, Zhen-Gang and Gao, Ke and Ren, Yu and Shen, Chong and Ying, Xiang-Rong},
title = {LRP8 Regulates Lipid Metabolism to Stimulate Malignant Progression and Cisplatin Resistance in Bladder Cancer},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2025},
volume = {41},
number = {9},
doi = {10.1002/kjm2.70042}
}
EUVIMED